HAZARD ARH
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.4M
- Transactions
- 57
- Companies
- 17
- Average per transaction
- $59,231
Who reported the payments
| Gilead | $3,253,847 |
| United Therapeutics Corporation | $28,088 |
| E.r. Squibb & Sons, L.L.C. | $23,416 |
| Concordance Healthcare Solutions, LLC | $21,115 |
| Takeda Pharmaceuticals U.S.A., Inc. | $8,627 |
| Biotronik Inc. | $8,550 |
| Bristol Myers Squibb | $6,077 |
| Baxter Healthcare | $5,799 |
| Incyte Corporation | $5,631 |
| Astrazeneca UK Limited | $3,852 |
| GE HealthCare | $3,799 |
| BD | $3,220 |
| Linvatec Corporation | $2,317 |
| Leica Microsystems Inc. | $1,085 |
| Olympus America Inc. | $405 |
| Edwards Lifesciences | $320 |
| Bio-rad Laboratories, Inc. | $30 |